CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 20,200 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $24,000 | -33.3% | 20,200 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $36,000 | -10.0% | 20,200 | +2.5% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -25.9% | 19,700 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | -52.2% | 19,850 | -21.7% | 0.00% | -60.0% |
| Q3 2021 | $113,000 | -17.5% | 25,350 | +7.6% | 0.01% | -16.7% |
| Q2 2021 | $137,000 | -0.7% | 23,550 | +19.8% | 0.01% | -25.0% |
| Q1 2021 | $138,000 | +62.4% | 19,650 | +10.7% | 0.01% | +14.3% |
| Q4 2020 | $85,000 | -8.6% | 17,750 | +11.3% | 0.01% | -22.2% |
| Q3 2020 | $93,000 | +6.9% | 15,950 | +23.2% | 0.01% | +12.5% |
| Q2 2020 | $87,000 | – | 12,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |